相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular properties affecting fast dissociation from the D2 receptor
Gary Tresadern et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Binding properties of antagonists to Cannabinoid receptors in intact cells
Marie Wennerberg et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2011)
Association of Candesartan vs Losartan With All-Cause Mortality in Patients With Heart Failure
Maria Eklind-Cervenka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Elusive equilibrium: the challenge of interpreting receptor pharmacology using calcium assays
Steven J. Charlton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Estimation of the dissociation rate of unlabelled ligand-receptor complexes by a 'two-step' competition binding approach
A. Packeu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action
Georges Vauquelin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time
Georges Vauquelin
EXPERT OPINION ON DRUG DISCOVERY (2010)
The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety
Robert A. Copeland
EXPERT OPINION ON DRUG DISCOVERY (2010)
Binding kinetics and mechanism of action: toward the discovery and development of better and best in class drugs
Rumin Zhang et al.
EXPERT OPINION ON DRUG DISCOVERY (2010)
Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension
S. E. Kjeldsen et al.
JOURNAL OF HUMAN HYPERTENSION (2010)
Structural Basis of Allosteric Ligand-Receptor Interactions in the Insulin/Relaxin Peptide Family Implications for Other Receptor Tyrosine Kinases and G-Protein-Coupled Receptors
Pierre De Meyts et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Molecular mechanisms for the persistent bronchodilatory effect of the beta(2)-adrenoceptor agonist salmeterol
A. Szczuka et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: Application to (R)-dimethindene occupancy of central histamine H1 receptors
Siobhan Malany et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2009)
Ligands, their receptors and ... plasma membranes
G. Vauquelin et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
OPINION Cellular assays as portals to seven-transmembrane receptor-based drug discovery
Terry P. Kenakin
NATURE REVIEWS DRUG DISCOVERY (2009)
Residence time of receptor-ligand complexes and its effect on biological function
Peter J. Tummino et al.
BIOCHEMISTRY (2008)
Kinetic versus allosteric mechanisms to explain insurmountable antagonism and delayed ligand dissociation
Georges Vauquelin et al.
NEUROCHEMISTRY INTERNATIONAL (2007)
Scintillation proximity assay as a high-throughput method to identify slowly dissociating nonpeptide ligand binding to the GnRH receptor
Christopher E. Heise et al.
JOURNAL OF BIOMOLECULAR SCREENING (2007)
Determining the potency and molecular mechanism of action of insurmountable antagonists
Terry Kenakin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Can binding kinetics translate to a clinically differentiated drug? From theory to practice
David C. Swinney
LETTERS IN DRUG DESIGN & DISCOVERY (2006)
Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor
Carol Smith et al.
MOLECULAR PHARMACOLOGY (2006)
Opinion - Drug-target residence time and its implications for lead optimization
Robert A. Copeland et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Slow antagonist dissociation and long-lasting in vivo receptor protection
Georges Vauquelin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartans
Georges Vauquelin et al.
JOURNAL OF HYPERTENSION (2006)
Biochemical mechanisms of new molecular entities (NMEs) approved by United States FDA during 2001-2004: Mechanisms leading to optimal efficacy and safety
David C. Swinney
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
An update of fast-off dopamine D2 atypical antipsychotics
P Seeman
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity
E Urizar et al.
EMBO JOURNAL (2005)
Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs
S Miyamoto et al.
MOLECULAR PSYCHIATRY (2005)
Effect of saponin and filipin on antagonist binding to AT1 receptors in intact cells
I Verheijen et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Allosteric modulation of G-protein coupled receptors
AA Jensen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Effects of the geometry of the immunological synapse on the delivery of effector molecules
D Coombs et al.
BIOPHYSICAL JOURNAL (2004)
Biochemical mechanisms of drug action: what does it take for success?
DC Swinney
NATURE REVIEWS DRUG DISCOVERY (2004)
Contribution of dead-space microdomains to tortuosity of brain extracellular space
S Hrabetová et al.
NEUROCHEMISTRY INTERNATIONAL (2004)
Models and methods for studying insurmountable antagonism
G Vauquelin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
New insights in insurmountable antagonism
G Vauquelin et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2002)
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors
KD Burris et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
G protein-coupled receptor allosterism and complexing
A Christopoulos et al.
PHARMACOLOGICAL REVIEWS (2002)
Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors
AC Holloway et al.
MOLECULAR PHARMACOLOGY (2002)
Distinct binding properties of the AT1 receptor antagonist [3H]candesartan to intact cells and membrane preparations
FLP Fierens et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel
MA Lovich et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists
G Vauquelin et al.
BIOCHEMICAL PHARMACOLOGY (2001)
分享论文
